232 filings
8-K
CRVO
CervoMed Inc
23 Apr 24
Regulation FD Disclosure
8:00am
8-K
CRVO
CervoMed Inc
5 Apr 24
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
4:06pm
8-K
CRVO
CervoMed Inc
4 Apr 24
Regulation FD Disclosure
7:00am
8-K
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
CRVO
CervoMed Inc
18 Mar 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:32pm
8-K
yopmy8l
5 Mar 24
Regulation FD Disclosure
8:51am
8-K
70aclj
28 Feb 24
Entry into a Material Definitive Agreement
4:15pm
8-K
mepmg vafo2qzq
7 Feb 24
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
4:06pm
8-K
g6zv9xvj420x84gmrp
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
x34vt48
5 Jan 24
CervoMed to Participate in the Emerging Growth Conference 66
4:05pm
8-K
pyd7r0y343j2sf7 kz
4 Jan 24
Regulation FD Disclosure
4:05pm
8-K
732845ppasl4f
21 Dec 23
Regulation FD Disclosure
4:05pm
8-K
qb2focc x8
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K
1o77y
13 Nov 23
CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights
4:06pm
8-K
97tb79a lnhog8fs
8 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
bka7i6m2qa25ebwurfn
31 Oct 23
Departure of Directors or Certain Officers
4:15pm
8-K
vh7po
25 Oct 23
Regulation FD Disclosure
5:18pm
8-K
g7xh7lkyfjc9u7b1 gg
3 Oct 23
Regulation FD Disclosure
5:00pm
8-K
2gniucqz4odujt6t6nt
6 Sep 23
Other Events
4:05pm
8-K
gsm306m006dn
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm